Lisa M. Wilson
Investor Relations Contact bei TYME TECHNOLOGIES, INC.
Profil
Lisa M.
Wilson is the founder of In-Site Communications, Inc. which was founded in 1995 where she holds the title of President.
Currently, Ms. Wilson is an Investor Relations Contact at Tyme Technologies, Inc. and Eton Pharmaceuticals, Inc. Ms. Wilson's former positions include Senior Vice President-Investor Relations at Centene Corp.
and Investor Relations at BioScrip, Inc.
Aktive Positionen von Lisa M. Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Investor Relations Contact | - |
| ETON PHARMACEUTICALS, INC. | Investor Relations Contact | - |
In-Site Communications, Inc.
 In-Site Communications, Inc. Investment ManagersFinance In-Site Communications, Inc. is a private company based in New York, NY. In-Site Communications, Inc. was founded by Lisa M. Wilson. | Founder | 01.01.1995 |
Ehemalige bekannte Positionen von Lisa M. Wilson
| Unternehmen | Position | Ende |
|---|---|---|
BioScrip, Inc.
 BioScrip, Inc. Managed Health CareHealth Services BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The company was founded in 1996 and is headquartered in Denver, CO. | Public Communications Contact | - |
| CENTENE CORPORATION | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CENTENE CORPORATION | Health Services |
| ETON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
BioScrip, Inc.
BioScrip, Inc. Managed Health CareHealth Services BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The company was founded in 1996 and is headquartered in Denver, CO. | Health Services |
In-Site Communications, Inc.
In-Site Communications, Inc. Investment ManagersFinance In-Site Communications, Inc. is a private company based in New York, NY. In-Site Communications, Inc. was founded by Lisa M. Wilson. | Finance |
